Ginkgo Bioworks Holdings, Inc. (DNA)
11.34
-1.07
(-8.62%)
USD |
NYSE |
Oct 07, 09:36
Ginkgo Bioworks Holdings Max Drawdown (5Y) : 99.10% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.10% |
| August 31, 2026 | 99.10% |
| July 31, 2026 | 99.10% |
| June 30, 2026 | 99.10% |
| May 31, 2026 | 99.10% |
| April 30, 2026 | 99.10% |
| March 31, 2026 | 99.10% |
| February 28, 2026 | 99.10% |
| January 31, 2026 | 99.10% |
| Date | Value |
|---|---|
| December 31, 2025 | 99.10% |
| November 30, 2025 | 99.10% |
| October 31, 2025 | 99.10% |
| September 30, 2025 | 99.10% |
| August 31, 2025 | 99.10% |
| July 31, 2025 | 99.10% |
| June 30, 2025 | 99.10% |
| May 31, 2025 | 99.10% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Sotera Health Co. | 79.47% |
| CareDx, Inc. | 94.87% |
| BillionToOne, Inc. | -- |
| Quest Diagnostics, Inc. | 28.60% |
| Labcorp Holdings, Inc. | 34.60% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -72.86 |
| Beta (5Y) | 1.786 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 82.29% |
| Historical Sharpe Ratio (5Y) | -0.6682 |
| Historical Sortino (5Y) | -1.203 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.29% |